S. Reiter

发表

Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis

C. Cooper, J. Reginster, O. Bruyère, 2015, Drugs & Aging.

Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis.

N. Goel, J. Reginster, A. Laslop, 2011, Rheumatology.

Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

Jean-Pierre Devogelaer, Patrick Emonts, René Rizzoli, 2016, Aging Clinical and Experimental Research.

[Hydro-MRI in inflammatory bowel diseases: a comparison with colonoscopy and histology].

K. Schunk, R. Wanitschke, A. Kern, 2001, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

GLP-1 Release in Man after Lower Large Bowel Resection or Intrarectal Glucose Administration

R. Kirchner, B. Göke, N. Samadi, 1998, Digestion.

EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT

N. Arden, J. Bijlsma, H. Hauselmann, 2008, Annals of the rheumatic diseases.

EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

G. Herrero-Beaumont, M. Doherty, N. Arden, 2005, Annals of the rheumatic diseases.

Eosinophilia in the cat: a retrospective study of 312 cases (1975 to 1986).

H. Erb, J. Randolph, S. Reiter, 1990 .

Management of Glucocorticoid-Induced Osteoporosis

C. Cooper, J. Reginster, R. Rizzoli, 2012, Calcified Tissue International.

Feeding resistance after parenteral hyperalimentation.

J. Hyams, M. A. Geertsma, S. Reiter, 1985, American journal of diseases of children.

Recurrent Intussusception

S. Reiter, O. Eklof, 1978, Acta radiologica: diagnosis.

Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies

A. Barton, J. Reginster, A. Laslop, 2011, Annals of the rheumatic diseases.

Acrodysostosis A case of peripheral dysostosis, nasal hypoplasia, mental retardation and impaired hearing

S. Reiter, 1978, Pediatric Radiology.

Therapeutics(ESCISIT) International Clinical Studies Including force of the Eular Standing Committee for management of hand osteoarthritis - report of a task Eular evidence based recommendations for the

M. Doherty, N. Arden, J. Bijlsma, 2006 .

A case of neurofibromatosis with severe osseous disease of the thoracic spine

S. Reiter, V. Hvorslev, 1979, Pediatric Radiology.

Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA

N. Goel, J. Reginster, A. Laslop, 2011, Current medical research and opinion.

How to define responders in osteoarthritis

C. Cooper, J. Reginster, O. Bruyère, 2013, Current medical research and opinion.

Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis

C. Cooper, J. Reginster, O. Bruyère, 2017, Drugs & Aging.

EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

G. Herrero-Beaumont, M. Doherty, N. Arden, 2005, Annals of the rheumatic diseases.

Extent and time course of pain intensity upon treatment with a topical diclofenac sodium patch versus placebo in acute traumatic injury based on a validated end point: post hoc analysis of a randomized placebo-controlled trial

W. Kirch, E. Mueller, S. Reiter, 2010, Expert opinion on pharmacotherapy.